Inve US ▾
AIAIRS

AirSculpt Technologies (AIRS) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 10, 2026

Source: earnings call transcript

AirSculpt Technologies delivered a second consecutive quarter of stable revenue and positive same-center case growth in Q2 FY26, driven by strategic investments in new GLP-1-focused procedures and enhanced marketing. While revenue saw a slight year-over-year decline and marketing costs impacted EBITDA, the company is expanding its addressable market and service portfolio, including a new partnership for Alloclay. Management remains focused on converting this stabilization into sustained profitable growth through improved same-center sales and marketing efficiency, despite a choppy consumer env

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.